🔴 Cardio Diagnostics Holdings is trading 9.5% down today amid possible broader healthcare weakness

Cardio Diagnostics Holdings is trading 9.5% down at $2.00, with broader healthcare weakness a possible factor and no confirmed company-specific catalyst identified.

• The August 20 investor call covered commercialization, AI-driven cardiovascular tests, reimbursement progress, and growth initiatives.
• The decline reversed the August 20 close of $2.21, which followed an 11.06% gain; no new company-specific negative announcement or confirmed catalyst directly explaining the August 21 decline was identified.